Logo
x

Search

Subscribe Now

All Posts by Date

Hologic Acquires Focal Therapeutics for $125M to Strengthen its Breast Surgery Platform

Hologic Acquires Focal Therapeutics for $125M to Strengthen its Breast Surgery Platform

  • October 3, 2018
GSK and Hitachi Chemical Signs a Three-year Agreement for T-cell Therapy

GSK and Hitachi Chemical Signs a Three-year Agreement for T-cell Therapy

  • October 3, 2018
Insmed Receives FDA Approval of Arikayce to Treat Mycobacterium Avium Complex (MAC) Lung Disease in Adults

Insmed Receives FDA Approval of Arikayce to Treat Mycobacterium Avium Complex (MAC) Lung Disease in Adults

  • October 3, 2018
Merck Partnered with Dragonfly for Development and Commercialization of Immunotherapies for $695M

Merck Partnered with Dragonfly for Development and Commercialization of Immunotherapies for $695M

  • October 3, 2018
Alnylam Launches Novel RNAi Therapeutic Onpattro (patisiran) in Germany

Alnylam Launches Novel RNAi Therapeutic Onpattro (patisiran) in Germany

  • October 3, 2018
Novartis Signs License and Equity Investment Agreement with Boston Pharmaceuticals

Novartis Signs License and Equity Investment Agreement with Boston Pharmaceuticals

  • October 3, 2018
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.